nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—ABCC3—lung cancer	0.187	0.484	CbGaD
Omeprazole—ABCG2—lung cancer	0.0911	0.235	CbGaD
Omeprazole—CYP1A1—lung cancer	0.0713	0.184	CbGaD
Omeprazole—ABCB1—lung cancer	0.0379	0.0978	CbGaD
Omeprazole—CYP1B1—Erlotinib—lung cancer	0.0214	0.0514	CbGbCtD
Omeprazole—CYP1B1—Paclitaxel—lung cancer	0.0196	0.047	CbGbCtD
Omeprazole—ABCG2—Topotecan—lung cancer	0.0188	0.0452	CbGbCtD
Omeprazole—ABCC3—Cisplatin—lung cancer	0.0182	0.0438	CbGbCtD
Omeprazole—ABCC3—Etoposide—lung cancer	0.0179	0.043	CbGbCtD
Omeprazole—ABCG2—Gefitinib—lung cancer	0.0172	0.0413	CbGbCtD
Omeprazole—ABCG2—Teniposide—lung cancer	0.0167	0.0401	CbGbCtD
Omeprazole—CYP1A1—Gefitinib—lung cancer	0.0159	0.0381	CbGbCtD
Omeprazole—CYP1B1—Docetaxel—lung cancer	0.0142	0.034	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—lung cancer	0.0122	0.0293	CbGbCtD
Omeprazole—ABCC3—Methotrexate—lung cancer	0.0118	0.0284	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—lung cancer	0.0106	0.0254	CbGbCtD
Omeprazole—ABCG2—Erlotinib—lung cancer	0.0102	0.0244	CbGbCtD
Omeprazole—CYP1A1—Erlotinib—lung cancer	0.0094	0.0226	CbGbCtD
Omeprazole—ABCG2—Paclitaxel—lung cancer	0.00932	0.0224	CbGbCtD
Omeprazole—ABCG2—Irinotecan—lung cancer	0.00919	0.0221	CbGbCtD
Omeprazole—CYP2C19—Gefitinib—lung cancer	0.00769	0.0185	CbGbCtD
Omeprazole—ABCG2—Cisplatin—lung cancer	0.00749	0.018	CbGbCtD
Omeprazole—CYP2C19—Teniposide—lung cancer	0.00746	0.0179	CbGbCtD
Omeprazole—ABCG2—Etoposide—lung cancer	0.00736	0.0177	CbGbCtD
Omeprazole—ABCB1—Topotecan—lung cancer	0.00679	0.0163	CbGbCtD
Omeprazole—ABCG2—Docetaxel—lung cancer	0.00674	0.0162	CbGbCtD
Omeprazole—CYP2C9—Gefitinib—lung cancer	0.0064	0.0154	CbGbCtD
Omeprazole—ABCB1—Gefitinib—lung cancer	0.00621	0.0149	CbGbCtD
Omeprazole—CYP2C9—Teniposide—lung cancer	0.0062	0.0149	CbGbCtD
Omeprazole—CYP2D6—Gefitinib—lung cancer	0.00585	0.014	CbGbCtD
Omeprazole—CYP2C8—Erlotinib—lung cancer	0.00542	0.013	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—lung cancer	0.00502	0.0121	CbGbCtD
Omeprazole—CYP2C8—Paclitaxel—lung cancer	0.00496	0.0119	CbGbCtD
Omeprazole—ABCG2—Methotrexate—lung cancer	0.00487	0.0117	CbGbCtD
Omeprazole—ABCB1—Vinorelbine—lung cancer	0.00478	0.0115	CbGbCtD
Omeprazole—CYP2D6—Vinorelbine—lung cancer	0.00451	0.0108	CbGbCtD
Omeprazole—CYP1A2—Erlotinib—lung cancer	0.0042	0.0101	CbGbCtD
Omeprazole—CYP3A4—Topotecan—lung cancer	0.00407	0.00976	CbGbCtD
Omeprazole—CYP2C8—Etoposide—lung cancer	0.00392	0.00941	CbGbCtD
Omeprazole—ABCB1—Crizotinib—lung cancer	0.00381	0.00913	CbGbCtD
Omeprazole—CYP3A4—Gefitinib—lung cancer	0.00372	0.00893	CbGbCtD
Omeprazole—ABCB1—Gemcitabine—lung cancer	0.00372	0.00893	CbGbCtD
Omeprazole—ABCB1—Erlotinib—lung cancer	0.00367	0.00881	CbGbCtD
Omeprazole—CYP3A4—Teniposide—lung cancer	0.00361	0.00866	CbGbCtD
Omeprazole—CYP2C9—Paclitaxel—lung cancer	0.00346	0.00831	CbGbCtD
Omeprazole—CYP2D6—Erlotinib—lung cancer	0.00346	0.0083	CbGbCtD
Omeprazole—ABCB1—Paclitaxel—lung cancer	0.00336	0.00806	CbGbCtD
Omeprazole—ABCB1—Irinotecan—lung cancer	0.00332	0.00796	CbGbCtD
Omeprazole—CYP1A2—Etoposide—lung cancer	0.00304	0.00729	CbGbCtD
Omeprazole—ABCB1—Vinblastine—lung cancer	0.00295	0.00707	CbGbCtD
Omeprazole—CYP3A4—Vinorelbine—lung cancer	0.00287	0.00688	CbGbCtD
Omeprazole—CYP2C9—Cisplatin—lung cancer	0.00278	0.00668	CbGbCtD
Omeprazole—CYP2D6—Vinblastine—lung cancer	0.00278	0.00666	CbGbCtD
Omeprazole—ABCB1—Cisplatin—lung cancer	0.0027	0.00649	CbGbCtD
Omeprazole—ABCB1—Etoposide—lung cancer	0.00266	0.00637	CbGbCtD
Omeprazole—ABCB1—Docetaxel—lung cancer	0.00243	0.00583	CbGbCtD
Omeprazole—CYP3A4—Crizotinib—lung cancer	0.00228	0.00547	CbGbCtD
Omeprazole—CYP3A4—Erlotinib—lung cancer	0.0022	0.00528	CbGbCtD
Omeprazole—CYP3A4—Paclitaxel—lung cancer	0.00201	0.00483	CbGbCtD
Omeprazole—CYP3A4—Irinotecan—lung cancer	0.00199	0.00477	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—lung cancer	0.00181	0.00435	CbGbCtD
Omeprazole—CYP3A4—Vinblastine—lung cancer	0.00177	0.00424	CbGbCtD
Omeprazole—ABCB1—Methotrexate—lung cancer	0.00175	0.00421	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—lung cancer	0.00171	0.0041	CbGbCtD
Omeprazole—CYP3A4—Etoposide—lung cancer	0.00159	0.00382	CbGbCtD
Omeprazole—CYP3A4—Docetaxel—lung cancer	0.00146	0.00349	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—lung cancer	0.00109	0.0026	CbGbCtD
Omeprazole—Rabeprazole—ABCG2—lung cancer	0.000487	0.207	CrCbGaD
Omeprazole—Pantoprazole—ABCG2—lung cancer	0.000487	0.207	CrCbGaD
Omeprazole—ATP4A—respiratory system—lung cancer	0.000401	0.114	CbGeAlD
Omeprazole—Rabeprazole—CYP1A1—lung cancer	0.000382	0.162	CrCbGaD
Omeprazole—Lansoprazole—ABCG2—lung cancer	0.000363	0.154	CrCbGaD
Omeprazole—ATP4A—epithelium—lung cancer	0.000335	0.095	CbGeAlD
Omeprazole—Lansoprazole—CYP1A1—lung cancer	0.000285	0.121	CrCbGaD
Omeprazole—CYP2C18—bronchus—lung cancer	0.000271	0.0769	CbGeAlD
Omeprazole—CYP1B1—mammary gland—lung cancer	0.000239	0.0679	CbGeAlD
Omeprazole—ABCC3—respiratory system—lung cancer	0.000204	0.0578	CbGeAlD
Omeprazole—Pantoprazole—ABCB1—lung cancer	0.000203	0.086	CrCbGaD
Omeprazole—CYP2C8—mammary gland—lung cancer	0.000183	0.052	CbGeAlD
Omeprazole—CYP2C9—mammary gland—lung cancer	0.000163	0.0462	CbGeAlD
Omeprazole—CYP1B1—respiratory system—lung cancer	0.00016	0.0452	CbGeAlD
Omeprazole—Lansoprazole—ABCB1—lung cancer	0.000151	0.0641	CrCbGaD
Omeprazole—CYP1A2—respiratory system—lung cancer	0.000114	0.0324	CbGeAlD
Omeprazole—CYP1A1—respiratory system—lung cancer	0.000113	0.032	CbGeAlD
Omeprazole—ABCC3—lung—lung cancer	0.000108	0.0307	CbGeAlD
Omeprazole—CYP11A1—lymph node—lung cancer	9.54e-05	0.027	CbGeAlD
Omeprazole—CYP1A1—epithelium—lung cancer	9.43e-05	0.0267	CbGeAlD
Omeprazole—CYP1A1—bronchus—lung cancer	9.29e-05	0.0263	CbGeAlD
Omeprazole—CYP1B1—lung—lung cancer	8.47e-05	0.024	CbGeAlD
Omeprazole—CYP1A1—trachea—lung cancer	8.34e-05	0.0236	CbGeAlD
Omeprazole—CYP1A1—cardiac atrium—lung cancer	7.83e-05	0.0222	CbGeAlD
Omeprazole—ABCC3—lymph node—lung cancer	7.41e-05	0.021	CbGeAlD
Omeprazole—ABCG2—bone marrow—lung cancer	6.97e-05	0.0197	CbGeAlD
Omeprazole—ABCG2—lung—lung cancer	6.31e-05	0.0179	CbGeAlD
Omeprazole—CYP1A2—lung—lung cancer	6.07e-05	0.0172	CbGeAlD
Omeprazole—CYP1A1—lung—lung cancer	5.99e-05	0.017	CbGeAlD
Omeprazole—ABCB1—respiratory system—lung cancer	5.86e-05	0.0166	CbGeAlD
Omeprazole—CYP1B1—lymph node—lung cancer	5.8e-05	0.0164	CbGeAlD
Omeprazole—ABCB1—epithelium—lung cancer	4.9e-05	0.0139	CbGeAlD
Omeprazole—ABCB1—trachea—lung cancer	4.33e-05	0.0123	CbGeAlD
Omeprazole—ABCG2—lymph node—lung cancer	4.32e-05	0.0122	CbGeAlD
Omeprazole—CYP1A1—lymph node—lung cancer	4.1e-05	0.0116	CbGeAlD
Omeprazole—Decreased appetite—Paclitaxel—lung cancer	3.55e-05	0.000304	CcSEcCtD
Omeprazole—Dry mouth—Docetaxel—lung cancer	3.53e-05	0.000303	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Doxorubicin—lung cancer	3.53e-05	0.000303	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Paclitaxel—lung cancer	3.52e-05	0.000302	CcSEcCtD
Omeprazole—Fatigue—Paclitaxel—lung cancer	3.52e-05	0.000302	CcSEcCtD
Omeprazole—Hepatitis—Methotrexate—lung cancer	3.51e-05	0.000301	CcSEcCtD
Omeprazole—Pollakiuria—Doxorubicin—lung cancer	3.51e-05	0.000301	CcSEcCtD
Omeprazole—Asthenia—Gemcitabine—lung cancer	3.5e-05	0.0003	CcSEcCtD
Omeprazole—Constipation—Paclitaxel—lung cancer	3.49e-05	0.000299	CcSEcCtD
Omeprazole—Pain—Paclitaxel—lung cancer	3.49e-05	0.000299	CcSEcCtD
Omeprazole—Confusional state—Docetaxel—lung cancer	3.49e-05	0.000299	CcSEcCtD
Omeprazole—Pharyngitis—Methotrexate—lung cancer	3.48e-05	0.000299	CcSEcCtD
Omeprazole—Urinary tract disorder—Methotrexate—lung cancer	3.46e-05	0.000297	CcSEcCtD
Omeprazole—Photosensitivity reaction—Doxorubicin—lung cancer	3.46e-05	0.000297	CcSEcCtD
Omeprazole—Anaphylactic shock—Docetaxel—lung cancer	3.46e-05	0.000297	CcSEcCtD
Omeprazole—Weight increased—Doxorubicin—lung cancer	3.45e-05	0.000296	CcSEcCtD
Omeprazole—Pruritus—Gemcitabine—lung cancer	3.45e-05	0.000296	CcSEcCtD
Omeprazole—Urethral disorder—Methotrexate—lung cancer	3.44e-05	0.000295	CcSEcCtD
Omeprazole—Infection—Docetaxel—lung cancer	3.44e-05	0.000295	CcSEcCtD
Omeprazole—ABCB1—bone marrow—lung cancer	3.43e-05	0.00974	CbGeAlD
Omeprazole—Weight decreased—Doxorubicin—lung cancer	3.43e-05	0.000295	CcSEcCtD
Omeprazole—Feeling abnormal—Etoposide—lung cancer	3.43e-05	0.000294	CcSEcCtD
Omeprazole—Diarrhoea—Irinotecan—lung cancer	3.42e-05	0.000294	CcSEcCtD
Omeprazole—Gastrointestinal pain—Etoposide—lung cancer	3.4e-05	0.000292	CcSEcCtD
Omeprazole—Shock—Docetaxel—lung cancer	3.4e-05	0.000292	CcSEcCtD
Omeprazole—Nervous system disorder—Docetaxel—lung cancer	3.39e-05	0.000291	CcSEcCtD
Omeprazole—Thrombocytopenia—Docetaxel—lung cancer	3.39e-05	0.000291	CcSEcCtD
Omeprazole—Infestation NOS—Doxorubicin—lung cancer	3.38e-05	0.00029	CcSEcCtD
Omeprazole—Infestation—Doxorubicin—lung cancer	3.38e-05	0.00029	CcSEcCtD
Omeprazole—Visual impairment—Methotrexate—lung cancer	3.38e-05	0.00029	CcSEcCtD
Omeprazole—Tachycardia—Docetaxel—lung cancer	3.38e-05	0.00029	CcSEcCtD
Omeprazole—Feeling abnormal—Paclitaxel—lung cancer	3.36e-05	0.000288	CcSEcCtD
Omeprazole—Skin disorder—Docetaxel—lung cancer	3.36e-05	0.000288	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.36e-05	0.000288	CcSEcCtD
Omeprazole—Hypersensitivity—Cisplatin—lung cancer	3.35e-05	0.000287	CcSEcCtD
Omeprazole—Gastrointestinal pain—Paclitaxel—lung cancer	3.34e-05	0.000286	CcSEcCtD
Omeprazole—Diarrhoea—Gemcitabine—lung cancer	3.33e-05	0.000286	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—lung cancer	3.33e-05	0.000285	CcSEcCtD
Omeprazole—Erythema multiforme—Methotrexate—lung cancer	3.32e-05	0.000285	CcSEcCtD
Omeprazole—Dizziness—Irinotecan—lung cancer	3.31e-05	0.000284	CcSEcCtD
Omeprazole—Urticaria—Etoposide—lung cancer	3.31e-05	0.000284	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—lung cancer	3.3e-05	0.000283	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—lung cancer	3.3e-05	0.000283	CcSEcCtD
Omeprazole—Anorexia—Docetaxel—lung cancer	3.3e-05	0.000283	CcSEcCtD
Omeprazole—Body temperature increased—Etoposide—lung cancer	3.29e-05	0.000282	CcSEcCtD
Omeprazole—Abdominal pain—Etoposide—lung cancer	3.29e-05	0.000282	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—lung cancer	3.29e-05	0.000282	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—lung cancer	3.29e-05	0.000282	CcSEcCtD
Omeprazole—Eye disorder—Methotrexate—lung cancer	3.28e-05	0.000281	CcSEcCtD
Omeprazole—Tinnitus—Methotrexate—lung cancer	3.27e-05	0.000281	CcSEcCtD
Omeprazole—Asthenia—Cisplatin—lung cancer	3.26e-05	0.00028	CcSEcCtD
Omeprazole—Urticaria—Paclitaxel—lung cancer	3.24e-05	0.000278	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—lung cancer	3.23e-05	0.000277	CcSEcCtD
Omeprazole—Abdominal pain—Paclitaxel—lung cancer	3.23e-05	0.000277	CcSEcCtD
Omeprazole—Body temperature increased—Paclitaxel—lung cancer	3.23e-05	0.000277	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—lung cancer	3.2e-05	0.000275	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—lung cancer	3.19e-05	0.000274	CcSEcCtD
Omeprazole—Vomiting—Irinotecan—lung cancer	3.18e-05	0.000273	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—lung cancer	3.17e-05	0.000272	CcSEcCtD
Omeprazole—Immune system disorder—Methotrexate—lung cancer	3.17e-05	0.000272	CcSEcCtD
Omeprazole—Mediastinal disorder—Methotrexate—lung cancer	3.16e-05	0.000271	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—lung cancer	3.16e-05	0.000271	CcSEcCtD
Omeprazole—Rash—Irinotecan—lung cancer	3.15e-05	0.000271	CcSEcCtD
Omeprazole—Dermatitis—Irinotecan—lung cancer	3.15e-05	0.00027	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Docetaxel—lung cancer	3.15e-05	0.00027	CcSEcCtD
Omeprazole—Chills—Methotrexate—lung cancer	3.15e-05	0.00027	CcSEcCtD
Omeprazole—Headache—Irinotecan—lung cancer	3.13e-05	0.000269	CcSEcCtD
Omeprazole—Insomnia—Docetaxel—lung cancer	3.13e-05	0.000268	CcSEcCtD
Omeprazole—ABCB1—lung—lung cancer	3.11e-05	0.00882	CbGeAlD
Omeprazole—Diarrhoea—Cisplatin—lung cancer	3.11e-05	0.000267	CcSEcCtD
Omeprazole—Paraesthesia—Docetaxel—lung cancer	3.11e-05	0.000266	CcSEcCtD
Omeprazole—Alopecia—Methotrexate—lung cancer	3.1e-05	0.000266	CcSEcCtD
Omeprazole—Vomiting—Gemcitabine—lung cancer	3.1e-05	0.000266	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—lung cancer	3.09e-05	0.000265	CcSEcCtD
Omeprazole—Dyspnoea—Docetaxel—lung cancer	3.08e-05	0.000265	CcSEcCtD
Omeprazole—Somnolence—Docetaxel—lung cancer	3.07e-05	0.000264	CcSEcCtD
Omeprazole—Mental disorder—Methotrexate—lung cancer	3.07e-05	0.000264	CcSEcCtD
Omeprazole—Rash—Gemcitabine—lung cancer	3.07e-05	0.000264	CcSEcCtD
Omeprazole—Dermatitis—Gemcitabine—lung cancer	3.07e-05	0.000263	CcSEcCtD
Omeprazole—Hypersensitivity—Etoposide—lung cancer	3.07e-05	0.000263	CcSEcCtD
Omeprazole—Malnutrition—Methotrexate—lung cancer	3.05e-05	0.000262	CcSEcCtD
Omeprazole—Headache—Gemcitabine—lung cancer	3.05e-05	0.000262	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—lung cancer	3.05e-05	0.000261	CcSEcCtD
Omeprazole—Dyspepsia—Docetaxel—lung cancer	3.04e-05	0.000261	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—lung cancer	3.04e-05	0.000261	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—lung cancer	3.02e-05	0.000259	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—lung cancer	3.02e-05	0.000259	CcSEcCtD
Omeprazole—Decreased appetite—Docetaxel—lung cancer	3.01e-05	0.000258	CcSEcCtD
Omeprazole—Hypersensitivity—Paclitaxel—lung cancer	3.01e-05	0.000258	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—lung cancer	3e-05	0.000257	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—lung cancer	2.99e-05	0.000257	CcSEcCtD
Omeprazole—Dysgeusia—Methotrexate—lung cancer	2.99e-05	0.000257	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Docetaxel—lung cancer	2.99e-05	0.000256	CcSEcCtD
Omeprazole—Asthenia—Etoposide—lung cancer	2.99e-05	0.000256	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—lung cancer	2.99e-05	0.000256	CcSEcCtD
Omeprazole—Fatigue—Docetaxel—lung cancer	2.98e-05	0.000256	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—lung cancer	2.98e-05	0.000256	CcSEcCtD
Omeprazole—Nausea—Irinotecan—lung cancer	2.97e-05	0.000255	CcSEcCtD
Omeprazole—Constipation—Docetaxel—lung cancer	2.96e-05	0.000254	CcSEcCtD
Omeprazole—Pain—Docetaxel—lung cancer	2.96e-05	0.000254	CcSEcCtD
Omeprazole—Back pain—Methotrexate—lung cancer	2.95e-05	0.000253	CcSEcCtD
Omeprazole—Pruritus—Etoposide—lung cancer	2.94e-05	0.000253	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—lung cancer	2.93e-05	0.000251	CcSEcCtD
Omeprazole—Asthenia—Paclitaxel—lung cancer	2.93e-05	0.000251	CcSEcCtD
Omeprazole—Nausea—Gemcitabine—lung cancer	2.89e-05	0.000248	CcSEcCtD
Omeprazole—Vomiting—Cisplatin—lung cancer	2.89e-05	0.000248	CcSEcCtD
Omeprazole—Pruritus—Paclitaxel—lung cancer	2.89e-05	0.000248	CcSEcCtD
Omeprazole—Vision blurred—Methotrexate—lung cancer	2.88e-05	0.000247	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—lung cancer	2.87e-05	0.000246	CcSEcCtD
Omeprazole—Rash—Cisplatin—lung cancer	2.86e-05	0.000246	CcSEcCtD
Omeprazole—Dermatitis—Cisplatin—lung cancer	2.86e-05	0.000245	CcSEcCtD
Omeprazole—Feeling abnormal—Docetaxel—lung cancer	2.85e-05	0.000245	CcSEcCtD
Omeprazole—Diarrhoea—Etoposide—lung cancer	2.85e-05	0.000244	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—lung cancer	2.84e-05	0.000244	CcSEcCtD
Omeprazole—Ill-defined disorder—Methotrexate—lung cancer	2.83e-05	0.000243	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—lung cancer	2.83e-05	0.000243	CcSEcCtD
Omeprazole—Gastrointestinal pain—Docetaxel—lung cancer	2.83e-05	0.000243	CcSEcCtD
Omeprazole—Anaemia—Methotrexate—lung cancer	2.82e-05	0.000242	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—lung cancer	2.82e-05	0.000242	CcSEcCtD
Omeprazole—Diarrhoea—Paclitaxel—lung cancer	2.79e-05	0.00024	CcSEcCtD
Omeprazole—Malaise—Methotrexate—lung cancer	2.75e-05	0.000236	CcSEcCtD
Omeprazole—Dizziness—Etoposide—lung cancer	2.75e-05	0.000236	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—lung cancer	2.74e-05	0.000235	CcSEcCtD
Omeprazole—Vertigo—Methotrexate—lung cancer	2.74e-05	0.000235	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—lung cancer	2.74e-05	0.000235	CcSEcCtD
Omeprazole—Abdominal pain—Docetaxel—lung cancer	2.73e-05	0.000235	CcSEcCtD
Omeprazole—Body temperature increased—Docetaxel—lung cancer	2.73e-05	0.000235	CcSEcCtD
Omeprazole—Leukopenia—Methotrexate—lung cancer	2.73e-05	0.000235	CcSEcCtD
Omeprazole—Chills—Doxorubicin—lung cancer	2.73e-05	0.000234	CcSEcCtD
Omeprazole—Dizziness—Paclitaxel—lung cancer	2.7e-05	0.000231	CcSEcCtD
Omeprazole—Nausea—Cisplatin—lung cancer	2.7e-05	0.000231	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—lung cancer	2.68e-05	0.00023	CcSEcCtD
Omeprazole—Cough—Methotrexate—lung cancer	2.67e-05	0.000229	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—lung cancer	2.66e-05	0.000228	CcSEcCtD
Omeprazole—Vomiting—Etoposide—lung cancer	2.65e-05	0.000227	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—lung cancer	2.64e-05	0.000227	CcSEcCtD
Omeprazole—Rash—Etoposide—lung cancer	2.62e-05	0.000225	CcSEcCtD
Omeprazole—Dermatitis—Etoposide—lung cancer	2.62e-05	0.000225	CcSEcCtD
Omeprazole—Headache—Etoposide—lung cancer	2.61e-05	0.000224	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—lung cancer	2.61e-05	0.000224	CcSEcCtD
Omeprazole—Arthralgia—Methotrexate—lung cancer	2.6e-05	0.000223	CcSEcCtD
Omeprazole—Myalgia—Methotrexate—lung cancer	2.6e-05	0.000223	CcSEcCtD
Omeprazole—Chest pain—Methotrexate—lung cancer	2.6e-05	0.000223	CcSEcCtD
Omeprazole—Tension—Doxorubicin—lung cancer	2.6e-05	0.000223	CcSEcCtD
Omeprazole—Vomiting—Paclitaxel—lung cancer	2.59e-05	0.000223	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—lung cancer	2.59e-05	0.000222	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.58e-05	0.000222	CcSEcCtD
Omeprazole—Rash—Paclitaxel—lung cancer	2.57e-05	0.000221	CcSEcCtD
Omeprazole—Dermatitis—Paclitaxel—lung cancer	2.57e-05	0.000221	CcSEcCtD
Omeprazole—Discomfort—Methotrexate—lung cancer	2.57e-05	0.00022	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—lung cancer	2.57e-05	0.00022	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—lung cancer	2.56e-05	0.000219	CcSEcCtD
Omeprazole—Headache—Paclitaxel—lung cancer	2.56e-05	0.000219	CcSEcCtD
Omeprazole—Hypersensitivity—Docetaxel—lung cancer	2.55e-05	0.000219	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—lung cancer	2.54e-05	0.000218	CcSEcCtD
Omeprazole—Confusional state—Methotrexate—lung cancer	2.51e-05	0.000216	CcSEcCtD
Omeprazole—Anaphylactic shock—Methotrexate—lung cancer	2.49e-05	0.000214	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—lung cancer	2.49e-05	0.000214	CcSEcCtD
Omeprazole—Asthenia—Docetaxel—lung cancer	2.48e-05	0.000213	CcSEcCtD
Omeprazole—Infection—Methotrexate—lung cancer	2.48e-05	0.000212	CcSEcCtD
Omeprazole—Nausea—Etoposide—lung cancer	2.47e-05	0.000212	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—lung cancer	2.45e-05	0.000211	CcSEcCtD
Omeprazole—Pruritus—Docetaxel—lung cancer	2.45e-05	0.00021	CcSEcCtD
Omeprazole—Nervous system disorder—Methotrexate—lung cancer	2.44e-05	0.00021	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—lung cancer	2.44e-05	0.00021	CcSEcCtD
Omeprazole—Thrombocytopenia—Methotrexate—lung cancer	2.44e-05	0.000209	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—lung cancer	2.43e-05	0.000209	CcSEcCtD
Omeprazole—Nausea—Paclitaxel—lung cancer	2.42e-05	0.000208	CcSEcCtD
Omeprazole—Skin disorder—Methotrexate—lung cancer	2.42e-05	0.000208	CcSEcCtD
Omeprazole—Hyperhidrosis—Methotrexate—lung cancer	2.41e-05	0.000207	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—lung cancer	2.38e-05	0.000205	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—lung cancer	2.38e-05	0.000204	CcSEcCtD
Omeprazole—Anorexia—Methotrexate—lung cancer	2.38e-05	0.000204	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—lung cancer	2.37e-05	0.000203	CcSEcCtD
Omeprazole—Diarrhoea—Docetaxel—lung cancer	2.37e-05	0.000203	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—lung cancer	2.34e-05	0.000201	CcSEcCtD
Omeprazole—Cough—Doxorubicin—lung cancer	2.31e-05	0.000198	CcSEcCtD
Omeprazole—Dizziness—Docetaxel—lung cancer	2.29e-05	0.000196	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—lung cancer	2.28e-05	0.000196	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methotrexate—lung cancer	2.27e-05	0.000195	CcSEcCtD
Omeprazole—Insomnia—Methotrexate—lung cancer	2.25e-05	0.000193	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—lung cancer	2.25e-05	0.000193	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—lung cancer	2.25e-05	0.000193	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—lung cancer	2.25e-05	0.000193	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—lung cancer	2.24e-05	0.000193	CcSEcCtD
Omeprazole—Paraesthesia—Methotrexate—lung cancer	2.24e-05	0.000192	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.24e-05	0.000192	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—lung cancer	2.22e-05	0.000191	CcSEcCtD
Omeprazole—Dyspnoea—Methotrexate—lung cancer	2.22e-05	0.000191	CcSEcCtD
Omeprazole—Somnolence—Methotrexate—lung cancer	2.22e-05	0.00019	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—lung cancer	2.2e-05	0.000189	CcSEcCtD
Omeprazole—Vomiting—Docetaxel—lung cancer	2.2e-05	0.000189	CcSEcCtD
Omeprazole—Dyspepsia—Methotrexate—lung cancer	2.19e-05	0.000188	CcSEcCtD
Omeprazole—Rash—Docetaxel—lung cancer	2.18e-05	0.000187	CcSEcCtD
Omeprazole—Dermatitis—Docetaxel—lung cancer	2.18e-05	0.000187	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—lung cancer	2.18e-05	0.000187	CcSEcCtD
Omeprazole—Decreased appetite—Methotrexate—lung cancer	2.17e-05	0.000186	CcSEcCtD
Omeprazole—Headache—Docetaxel—lung cancer	2.17e-05	0.000186	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—lung cancer	2.16e-05	0.000185	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Methotrexate—lung cancer	2.15e-05	0.000185	CcSEcCtD
Omeprazole—Fatigue—Methotrexate—lung cancer	2.15e-05	0.000184	CcSEcCtD
Omeprazole—Infection—Doxorubicin—lung cancer	2.14e-05	0.000184	CcSEcCtD
Omeprazole—Pain—Methotrexate—lung cancer	2.13e-05	0.000183	CcSEcCtD
Omeprazole—ABCB1—lymph node—lung cancer	2.13e-05	0.00603	CbGeAlD
Omeprazole—Shock—Doxorubicin—lung cancer	2.12e-05	0.000182	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—lung cancer	2.12e-05	0.000182	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—lung cancer	2.11e-05	0.000181	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—lung cancer	2.11e-05	0.000181	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—lung cancer	2.1e-05	0.00018	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—lung cancer	2.09e-05	0.000179	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—lung cancer	2.06e-05	0.000177	CcSEcCtD
Omeprazole—Nausea—Docetaxel—lung cancer	2.05e-05	0.000176	CcSEcCtD
Omeprazole—Feeling abnormal—Methotrexate—lung cancer	2.05e-05	0.000176	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methotrexate—lung cancer	2.04e-05	0.000175	CcSEcCtD
Omeprazole—Urticaria—Methotrexate—lung cancer	1.98e-05	0.00017	CcSEcCtD
Omeprazole—Body temperature increased—Methotrexate—lung cancer	1.97e-05	0.000169	CcSEcCtD
Omeprazole—Abdominal pain—Methotrexate—lung cancer	1.97e-05	0.000169	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.97e-05	0.000169	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—lung cancer	1.95e-05	0.000167	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—lung cancer	1.94e-05	0.000166	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—lung cancer	1.92e-05	0.000165	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—lung cancer	1.92e-05	0.000165	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—lung cancer	1.9e-05	0.000163	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—lung cancer	1.88e-05	0.000161	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—lung cancer	1.86e-05	0.00016	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—lung cancer	1.86e-05	0.00016	CcSEcCtD
Omeprazole—Pain—Doxorubicin—lung cancer	1.85e-05	0.000158	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—lung cancer	1.85e-05	0.000158	CcSEcCtD
Omeprazole—Hypersensitivity—Methotrexate—lung cancer	1.84e-05	0.000158	CcSEcCtD
Omeprazole—Asthenia—Methotrexate—lung cancer	1.79e-05	0.000153	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—lung cancer	1.78e-05	0.000153	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—lung cancer	1.76e-05	0.000151	CcSEcCtD
Omeprazole—Pruritus—Methotrexate—lung cancer	1.76e-05	0.000151	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—lung cancer	1.71e-05	0.000147	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—lung cancer	1.71e-05	0.000146	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—lung cancer	1.71e-05	0.000146	CcSEcCtD
Omeprazole—Diarrhoea—Methotrexate—lung cancer	1.71e-05	0.000146	CcSEcCtD
Omeprazole—Dizziness—Methotrexate—lung cancer	1.65e-05	0.000141	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—lung cancer	1.59e-05	0.000136	CcSEcCtD
Omeprazole—Vomiting—Methotrexate—lung cancer	1.58e-05	0.000136	CcSEcCtD
Omeprazole—Rash—Methotrexate—lung cancer	1.57e-05	0.000135	CcSEcCtD
Omeprazole—Dermatitis—Methotrexate—lung cancer	1.57e-05	0.000135	CcSEcCtD
Omeprazole—Headache—Methotrexate—lung cancer	1.56e-05	0.000134	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—lung cancer	1.55e-05	0.000133	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—lung cancer	1.53e-05	0.000131	CcSEcCtD
Omeprazole—Nausea—Methotrexate—lung cancer	1.48e-05	0.000127	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—lung cancer	1.48e-05	0.000127	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—lung cancer	1.43e-05	0.000122	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—lung cancer	1.37e-05	0.000118	CcSEcCtD
Omeprazole—Rash—Doxorubicin—lung cancer	1.36e-05	0.000117	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—lung cancer	1.36e-05	0.000117	CcSEcCtD
Omeprazole—Headache—Doxorubicin—lung cancer	1.35e-05	0.000116	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—lung cancer	1.28e-05	0.00011	CcSEcCtD
Omeprazole—CYP1A2—Metabolism—NCOA3—lung cancer	3.11e-06	4.24e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP2E1—lung cancer	3.1e-06	4.24e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.1e-06	4.23e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—STK11—lung cancer	3.1e-06	4.23e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTA4—lung cancer	3.08e-06	4.2e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NQO1—lung cancer	3.07e-06	4.19e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.05e-06	4.17e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CD—lung cancer	3.04e-06	4.16e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CAT—lung cancer	3.04e-06	4.15e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP2E1—lung cancer	3.03e-06	4.13e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTEN—lung cancer	3.02e-06	4.13e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.02e-06	4.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCG2—lung cancer	3.02e-06	4.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ADCY1—lung cancer	3.02e-06	4.13e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ALB—lung cancer	3e-06	4.1e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3e-06	4.1e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTA2—lung cancer	3e-06	4.1e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—POMC—lung cancer	3e-06	4.1e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NQO1—lung cancer	2.99e-06	4.09e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.97e-06	4.06e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—EP300—lung cancer	2.97e-06	4.05e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HPGDS—lung cancer	2.96e-06	4.05e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ENO2—lung cancer	2.96e-06	4.05e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ABCB1—lung cancer	2.96e-06	4.04e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.94e-06	4.02e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CREBBP—lung cancer	2.92e-06	3.99e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.91e-06	3.97e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.91e-06	3.97e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TYMS—lung cancer	2.9e-06	3.97e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTA1—lung cancer	2.89e-06	3.95e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—EP300—lung cancer	2.88e-06	3.94e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTT1—lung cancer	2.87e-06	3.93e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTM1—lung cancer	2.87e-06	3.92e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTP1—lung cancer	2.86e-06	3.91e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCC3—lung cancer	2.86e-06	3.91e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	2.85e-06	3.9e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP2E1—lung cancer	2.85e-06	3.9e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2A6—lung cancer	2.84e-06	3.88e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GCLC—lung cancer	2.84e-06	3.88e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.83e-06	3.87e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP2E1—lung cancer	2.83e-06	3.86e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NQO1—lung cancer	2.82e-06	3.85e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NQO1—lung cancer	2.8e-06	3.82e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CAT—lung cancer	2.79e-06	3.81e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.77e-06	3.79e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKR1C1—lung cancer	2.77e-06	3.78e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CD—lung cancer	2.77e-06	3.78e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—STK11—lung cancer	2.76e-06	3.77e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.74e-06	3.74e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ALB—lung cancer	2.73e-06	3.73e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.71e-06	3.7e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ABCB1—lung cancer	2.71e-06	3.7e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ERCC2—lung cancer	2.7e-06	3.69e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—STK11—lung cancer	2.7e-06	3.68e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ENO1—lung cancer	2.69e-06	3.68e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—UGT1A1—lung cancer	2.69e-06	3.67e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.68e-06	3.67e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TYMS—lung cancer	2.66e-06	3.64e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CB—lung cancer	2.65e-06	3.62e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.65e-06	3.62e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTM1—lung cancer	2.63e-06	3.6e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—lung cancer	2.63e-06	3.59e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.59e-06	3.54e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GNG11—lung cancer	2.59e-06	3.54e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTP1—lung cancer	2.56e-06	3.49e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—STK11—lung cancer	2.54e-06	3.47e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—lung cancer	2.54e-06	3.46e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—STK11—lung cancer	2.52e-06	3.44e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTP1—lung cancer	2.5e-06	3.41e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1A1—lung cancer	2.5e-06	3.41e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CAT—lung cancer	2.49e-06	3.4e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ERCC2—lung cancer	2.47e-06	3.38e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.47e-06	3.38e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDOA—lung cancer	2.47e-06	3.37e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CAT—lung cancer	2.43e-06	3.32e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCB1—lung cancer	2.42e-06	3.31e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2E1—lung cancer	2.42e-06	3.3e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CB—lung cancer	2.41e-06	3.3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOA3—lung cancer	2.4e-06	3.27e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—lung cancer	2.39e-06	3.27e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NQO1—lung cancer	2.39e-06	3.26e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TYMS—lung cancer	2.38e-06	3.25e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.37e-06	3.23e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTP1—lung cancer	2.35e-06	3.21e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTM1—lung cancer	2.35e-06	3.21e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.34e-06	3.2e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APOA1—lung cancer	2.34e-06	3.19e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCG2—lung cancer	2.33e-06	3.19e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ADCY1—lung cancer	2.33e-06	3.19e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTP1—lung cancer	2.33e-06	3.18e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TYMS—lung cancer	2.32e-06	3.17e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.32e-06	3.17e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTM1—lung cancer	2.29e-06	3.13e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—lung cancer	2.29e-06	3.13e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CAT—lung cancer	2.29e-06	3.13e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ENO2—lung cancer	2.29e-06	3.12e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HPGDS—lung cancer	2.29e-06	3.12e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.27e-06	3.1e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CAT—lung cancer	2.27e-06	3.1e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.26e-06	3.08e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.24e-06	3.05e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1A1—lung cancer	2.23e-06	3.04e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCB1—lung cancer	2.23e-06	3.04e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTT1—lung cancer	2.22e-06	3.03e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ERCC2—lung cancer	2.21e-06	3.02e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCB1—lung cancer	2.21e-06	3.01e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—lung cancer	2.19e-06	3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GCLC—lung cancer	2.19e-06	3e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2A6—lung cancer	2.19e-06	3e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMS—lung cancer	2.19e-06	2.99e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—EP300—lung cancer	2.19e-06	2.99e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1A1—lung cancer	2.17e-06	2.97e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMS—lung cancer	2.17e-06	2.96e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTM1—lung cancer	2.16e-06	2.95e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ERCC2—lung cancer	2.16e-06	2.95e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—STK11—lung cancer	2.15e-06	2.94e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTM1—lung cancer	2.14e-06	2.93e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APOA1—lung cancer	2.14e-06	2.92e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—lung cancer	2.13e-06	2.91e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CG—lung cancer	2.13e-06	2.91e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—lung cancer	2.09e-06	2.85e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ENO1—lung cancer	2.08e-06	2.84e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—lung cancer	2.07e-06	2.83e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.05e-06	2.8e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1A1—lung cancer	2.05e-06	2.8e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ERCC2—lung cancer	2.03e-06	2.78e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1A1—lung cancer	2.03e-06	2.77e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—POMC—lung cancer	2.03e-06	2.77e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.02e-06	2.76e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ERCC2—lung cancer	2.01e-06	2.75e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTP1—lung cancer	1.99e-06	2.72e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—EP300—lung cancer	1.99e-06	2.72e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CREBBP—lung cancer	1.98e-06	2.7e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CG—lung cancer	1.95e-06	2.67e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CAT—lung cancer	1.94e-06	2.65e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.93e-06	2.63e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APOA1—lung cancer	1.91e-06	2.61e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCB1—lung cancer	1.89e-06	2.58e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CD—lung cancer	1.87e-06	2.56e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APOA1—lung cancer	1.87e-06	2.55e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2E1—lung cancer	1.86e-06	2.55e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—POMC—lung cancer	1.86e-06	2.54e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMS—lung cancer	1.85e-06	2.53e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALB—lung cancer	1.85e-06	2.53e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NQO1—lung cancer	1.84e-06	2.52e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTM1—lung cancer	1.83e-06	2.5e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.83e-06	2.5e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CREBBP—lung cancer	1.81e-06	2.48e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—lung cancer	1.79e-06	2.45e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APOA1—lung cancer	1.76e-06	2.4e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CG—lung cancer	1.74e-06	2.38e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—lung cancer	1.74e-06	2.38e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APOA1—lung cancer	1.74e-06	2.38e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1A1—lung cancer	1.74e-06	2.37e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ERCC2—lung cancer	1.72e-06	2.35e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CD—lung cancer	1.72e-06	2.35e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CG—lung cancer	1.7e-06	2.33e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALB—lung cancer	1.7e-06	2.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.67e-06	2.28e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—STK11—lung cancer	1.66e-06	2.27e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—POMC—lung cancer	1.66e-06	2.27e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CB—lung cancer	1.63e-06	2.23e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—POMC—lung cancer	1.62e-06	2.21e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—lung cancer	1.62e-06	2.21e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CREBBP—lung cancer	1.62e-06	2.21e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—lung cancer	1.62e-06	2.21e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CG—lung cancer	1.6e-06	2.19e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CG—lung cancer	1.59e-06	2.17e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CREBBP—lung cancer	1.58e-06	2.16e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTP1—lung cancer	1.54e-06	2.1e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CD—lung cancer	1.53e-06	2.1e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—POMC—lung cancer	1.53e-06	2.09e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—POMC—lung cancer	1.51e-06	2.07e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALB—lung cancer	1.51e-06	2.07e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CB—lung cancer	1.5e-06	2.05e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CD—lung cancer	1.5e-06	2.05e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CAT—lung cancer	1.5e-06	2.04e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APOA1—lung cancer	1.49e-06	2.03e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CREBBP—lung cancer	1.49e-06	2.03e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—lung cancer	1.48e-06	2.03e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALB—lung cancer	1.48e-06	2.02e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CREBBP—lung cancer	1.47e-06	2.01e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—lung cancer	1.47e-06	2.01e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCB1—lung cancer	1.46e-06	1.99e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMS—lung cancer	1.43e-06	1.95e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.43e-06	1.95e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTM1—lung cancer	1.41e-06	1.93e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—lung cancer	1.41e-06	1.93e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CD—lung cancer	1.41e-06	1.93e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CD—lung cancer	1.4e-06	1.91e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALB—lung cancer	1.39e-06	1.9e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALB—lung cancer	1.38e-06	1.89e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CG—lung cancer	1.36e-06	1.86e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—EP300—lung cancer	1.35e-06	1.84e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1A1—lung cancer	1.34e-06	1.83e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CB—lung cancer	1.34e-06	1.83e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ERCC2—lung cancer	1.33e-06	1.81e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—lung cancer	1.32e-06	1.81e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—lung cancer	1.32e-06	1.8e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CB—lung cancer	1.3e-06	1.78e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—lung cancer	1.29e-06	1.77e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—POMC—lung cancer	1.29e-06	1.77e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—lung cancer	1.29e-06	1.77e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CREBBP—lung cancer	1.26e-06	1.72e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—EP300—lung cancer	1.23e-06	1.69e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CB—lung cancer	1.23e-06	1.68e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CB—lung cancer	1.22e-06	1.67e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—lung cancer	1.22e-06	1.66e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—lung cancer	1.21e-06	1.65e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—lung cancer	1.2e-06	1.64e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CD—lung cancer	1.2e-06	1.63e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALB—lung cancer	1.18e-06	1.61e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—lung cancer	1.16e-06	1.58e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APOA1—lung cancer	1.15e-06	1.57e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—lung cancer	1.13e-06	1.54e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—EP300—lung cancer	1.1e-06	1.5e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—EP300—lung cancer	1.08e-06	1.47e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—lung cancer	1.06e-06	1.45e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—lung cancer	1.05e-06	1.44e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CG—lung cancer	1.05e-06	1.43e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CB—lung cancer	1.04e-06	1.42e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—lung cancer	1.03e-06	1.41e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—EP300—lung cancer	1.01e-06	1.38e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—EP300—lung cancer	1e-06	1.37e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—POMC—lung cancer	9.99e-07	1.36e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—lung cancer	9.96e-07	1.36e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CREBBP—lung cancer	9.73e-07	1.33e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CD—lung cancer	9.22e-07	1.26e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—lung cancer	9.13e-07	1.25e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALB—lung cancer	9.1e-07	1.24e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—lung cancer	9e-07	1.23e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—EP300—lung cancer	8.58e-07	1.17e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—lung cancer	8.15e-07	1.11e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—lung cancer	8.14e-07	1.11e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CB—lung cancer	8.04e-07	1.1e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—lung cancer	7.97e-07	1.09e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—lung cancer	7.95e-07	1.09e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—lung cancer	7.5e-07	1.02e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—lung cancer	7.46e-07	1.02e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—lung cancer	7.43e-07	1.02e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—lung cancer	6.95e-07	9.49e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—lung cancer	6.66e-07	9.09e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—EP300—lung cancer	6.62e-07	9.05e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—lung cancer	6.5e-07	8.88e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—lung cancer	6.35e-07	8.67e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—lung cancer	6.12e-07	8.36e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—lung cancer	6.07e-07	8.29e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—lung cancer	5.19e-07	7.09e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—lung cancer	4.9e-07	6.69e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—lung cancer	4e-07	5.47e-06	CbGpPWpGaD
